Ticker AUTL – Autolus Therapeutics – sales, description, marketcap – Tickerday.com

AUTL

Autolus Therapeutics

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 627.00M; Volume: 74.57K; AvgVol 3m: 157.95K; Beta: ;

Cost estimate:

P/E: ; EPS: -2.78; EPS growth quarter/prev quarter: 5.70%;

EPS growth this year: -448.30%; EPS growth past 5 years: ;

EPS ttm: -2.74;

P/S: 552.11; P/B: 2.43; P/Cashflow: 3.13; P/FCF: ;

Sales: 1.24M; Sales growth quarter/prev quarter: 0.00%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -41.10%; ROE – return on equity: -48.60%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 26.63%; Insider Transactions:0.00%;

Institutional Ownership: 29.40%; Institutional Transactions: -9.07%;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *